Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 23Prostatic Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 3Thyroid Nodule 2Stomach Neoplasms 2Pleural Effusion, Malignant 2Mouth Neoplasms 2Fibrosis 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Uterine Hemorrhage 1Unspecified Adult Solid Tumor, Protocol Specific 1Thromboembolism 1Stomatitis 1Somatostatinoma 1Small Cell Lung Carcinoma 1Sarcoma, Endometrial Stromal 1Risk Malignant Index 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neurofibrosarcoma 1Neurofibromatosis 1 1Neoplasms 1Melanoma 1Lymphedema 1

Interventions

High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Risk Malignant Index × High-Energy Shock Waves × Clear all
NCT03404687 2018-01-19

Risk of Malignancy Index and Assiut Scoring Model for Adnexal Malignancy

Assiut University

Completed
250 enrolled

Risk Malignant Index

Data powered by HemOnc (CC BY 4.0) Colophon âš¡